Cognition Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Cognition Therapeutics Inc.
- Former names
- Cognition Theraputics Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Purchase
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CGTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001455365
Board of directors
-
Aaron G.l. Fletcher · DirectorSince 2023
-
Brett P. Monia · DirectorSince 2023
-
Ellen B. Richstone · DirectorSince 2023
-
Jack A. Khattar · DirectorSince 2023
-
Leslie W. Kreis · DirectorSince 2023
-
Lisa Ricciardi · Director · CEO & PresidentSince 2023
-
Peggy Wallace · DirectorSince 2023
Chief executives
Lisa Ricciardi
· CEO & President
Dates unknown
Director election results
Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.7%
-
95.7%
Board connections
5 of this board's directors also sit on 5 other boards.
- via Aaron G.l. Fletcher and Leslie W. Kreis
- via Aaron G.l. Fletcher
- via Brett P. Monia
- via Ellen B. Richstone
- via Jack A. Khattar
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $32,493
- 3 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | Jack A. Khattar Director | Grant or award | +25,000 | — | — |
| Jun 17, 2026 | Brett P. Monia Director | Grant or award | +25,000 | — | — |
| Jun 17, 2026 | Peggy Wallace Director | Grant or award | +25,000 | — | — |
| Jun 17, 2026 | Ellen B. Richstone Director | Grant or award | +25,000 | — | — |
| Jun 17, 2026 | BIOS Memory SPV I, LP Director, 10% owner | Grant or award | +25,000 | — | — |
| May 1, 2026 | Doyle John Brendan Officer (Chief Financial Officer) | Shares withheld for tax | −8,567 | $1.28 | $10,966 |
| Apr 16, 2026 | Doyle John Brendan Officer (Chief Financial Officer) | Open-market purchase | +10,000 | $1.13 | $11,300 |
| Apr 16, 2026 | Lisa Ricciardi Director, Officer (CEO & President) | Open-market purchase | +9,175 | $1.10 | $10,093 |
| Apr 16, 2026 | Caggiano Anthony Officer (Chief Medical Officer) | Open-market purchase | +10,000 | $1.11 | $11,100 |
| Feb 15, 2026 | Lisa Ricciardi Director, Officer (CEO & President) | Shares withheld for tax | −5,850 | $1.12 | $6,552 |
| Feb 15, 2026 | Doyle John Brendan Officer (Chief Financial Officer) | Shares withheld for tax | −1,560 | $1.12 | $1,747 |
| Feb 15, 2026 | Caggiano Anthony Officer (Chief Medical Officer) | Shares withheld for tax | −4,680 | $1.12 | $5,242 |
| Feb 4, 2026 | Doyle John Brendan Officer (Chief Financial Officer) | Shares withheld for tax | −26,921 | $1.03 | $27,729 |
| Feb 4, 2026 | Lisa Ricciardi Director, Officer (CEO & President) | Shares withheld for tax | −51,704 | $1.03 | $53,255 |
| Feb 4, 2026 | Caggiano Anthony Officer (Chief Medical Officer) | Shares withheld for tax | −26,919 | $1.03 | $27,727 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.